Mark J. Fitzpatrick
Director/Board Member bei ALLENA PHARMACEUTICALS, INC.
Profil
Mark J.
Fitzpatrick currently works at Versantis AG, as Chief Executive Officer & Director from 2021 and Allena Pharmaceuticals, Inc., as Independent Director from 2021.
Mr. Fitzpatrick also formerly worked at Repligen Corp., as Principal, Diacrin, Inc. (Delaware), as Chief Financial Officer & Vice President from 1991 to 1998, Dynogen Pharmaceuticals, Inc., as Chief Financial Officer from 1998 to 2009, Proteon Therapeutics, Inc., as Chief Financial Officer & Vice President from 2007 to 2011, Aegerion Pharmaceuticals, Inc., as Chief Financial Officer from 2011 to 2015, Chiasma, Inc., as President & Chief Financial Officer from 2019 to 2021, RenaMed Biologics, Inc., as Chief Financial Officer, WorldStreet Corp., as Chief Financial Officer & Senior Vice President from 1998 to 2002, and Arthur Andersen LLP, as Senior Auditor.
Mr. Fitzpatrick received his undergraduate degree in 1984 from Boston College.
Aktive Positionen von Mark J. Fitzpatrick
| Unternehmen | Position | Beginn |
|---|---|---|
| ALLENA PHARMACEUTICALS, INC. | Director/Board Member | 06.04.2021 |
Ehemalige bekannte Positionen von Mark J. Fitzpatrick
| Unternehmen | Position | Ende |
|---|---|---|
| CHIASMA, INC. | Chief Executive Officer | 17.06.2019 |
| AEGERION PHARMACEUTICALS, INC. | Director of Finance/CFO | 01.06.2015 |
| PROTARA THERAPEUTICS, INC. | Director of Finance/CFO | 01.05.2011 |
Dynogen Pharmaceuticals, Inc.
 Dynogen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dynogen Pharmaceuticals, Inc. develops and manufactures drugs. The company makes drugs for genitourinary and gastrointestinal disorders. It also makes drugs for constipation, Irritable Bowel Syndrome and overactive bladder. Dynogen Pharmaceuticals was founded by Lee R. Brettman in 2002 and is located in Waltham, MA. | Director of Finance/CFO | 13.11.2009 |
RenaMed Biologics, Inc.
 RenaMed Biologics, Inc. Medical/Nursing ServicesHealth Services RenaMed Biologics, Inc. provided clinical cellular therapy. The company was founded by H. David Humes, James P. Sherblom and Richard A. Andrews in 1995 and was headquartered in Lincoln, RI. | Director of Finance/CFO | - |
Ausbildung von Mark J. Fitzpatrick
| Boston College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| REPLIGEN CORPORATION | Health Technology |
| ALLENA PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 8 |
|---|---|
Diacrin, Inc. (Delaware)
 Diacrin, Inc. (Delaware) Medical SpecialtiesHealth Technology Diacrin, Inc. develops human cell transplant therapeutic products. The company is headquartered in Wilmington, DE. | Health Technology |
Dynogen Pharmaceuticals, Inc.
Dynogen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dynogen Pharmaceuticals, Inc. develops and manufactures drugs. The company makes drugs for genitourinary and gastrointestinal disorders. It also makes drugs for constipation, Irritable Bowel Syndrome and overactive bladder. Dynogen Pharmaceuticals was founded by Lee R. Brettman in 2002 and is located in Waltham, MA. | Health Technology |
Proteon Therapeutics, Inc.
 Proteon Therapeutics, Inc. BiotechnologyHealth Technology Proteon Therapeutics, Inc. engages in the research and development of biopharmaceutical products. It produces and commercializes vonapanitase for the treatment of renal and vascular disease. The company was founded by F. Nicholas Franano and William P. Whitaker in 2001 and is headquartered in Waltham, MA. | Health Technology |
Aegerion Pharmaceuticals, Inc.
 Aegerion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aegerion Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the development and commercialization of therapies for patients with debilitating rare diseases. The company was founded by David I. Scheer, Gerald L. Wisler and William H. Lewis in 2005 and is headquartered in Cambridge, MA. | Health Technology |
Chiasma, Inc.
 Chiasma, Inc. Pharmaceuticals: MajorHealth Technology Chiasma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of oral forms of therapies that are available by injection. Its products include octreotide capsules. The company was founded by Shmuel A. Ben-Sasson and Guy Yachin in 2001 and is headquartered in Needham, MA. | Health Technology |
RenaMed Biologics, Inc.
RenaMed Biologics, Inc. Medical/Nursing ServicesHealth Services RenaMed Biologics, Inc. provided clinical cellular therapy. The company was founded by H. David Humes, James P. Sherblom and Richard A. Andrews in 1995 and was headquartered in Lincoln, RI. | Health Services |
WorldStreet Corp.
 WorldStreet Corp. Packaged SoftwareTechnology Services WorldStreet Corp. develops enterprise software applications. The American company was founded by Paul I. Walborsky. | Technology Services |
Arthur Andersen LLP
 Arthur Andersen LLP Miscellaneous Commercial ServicesCommercial Services Arthur Andersen LLP used to provide accounting services. It was also into consulting services for clients that operate businesses throughout the United States and around the world. Arthur Andersen was founded in 1913 and was headquartered in Chicago, IL. | Commercial Services |
